New York University [NYU] School of Medicine

New York, New York 10016

0 studies enrolling now · 2 studies all time

What they study most

Glycogen Storage Disease Type II, Hepatic Encephalopathy, Pompe Disease Infantile-Onset

Studies at this site

• Efficacy and Safety of AXA1665 in Cirrhotic Subjects With Prior Overt Hepatic Encephalopathy — Stopped early
• Extension Study of Long-term Safety and Efficacy of Myozyme in Patients With Pompe Disease Who Were Previously Enrolled in Genzyme Sponsored Enzyme Replacement Therapy (ERT) Studies — Completed